Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Optical Coherence Tomography Imaging of the Lamina Cribrosa: Structural Biomarkers in Nonglaucomatous Diseases
Publication

Publications

Optical Coherence Tomography Imaging of the Lamina Cribrosa: Structural Biomarkers in Nonglaucomatous Diseases

Title
Optical Coherence Tomography Imaging of the Lamina Cribrosa: Structural Biomarkers in Nonglaucomatous Diseases
Type
Article in International Scientific Journal
Year
2021
Authors
Paulo, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Vaz, PG
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
De Jesus, DA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Brea, LS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Van Eijgen, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Cardoso, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
van Walsum, T
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Klein, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Stalmans, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Breda, JB
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 2021
Pages: 1-31
ISSN: 2090-004X
Publisher: Hindawi
Other information
Authenticus ID: P-00T-N3S
Resumo (PT):
Abstract (EN): The lamina cribrosa (LC) is an active structure that responds to the strain by changing its morphology. Abnormal changes in LC morphology are usually associated with, and indicative of, certain pathologies such as glaucoma, intraocular hypertension, and myopia. Recent developments in optical coherence tomography (OCT) have enabled detailed in vivo studies about the architectural characteristics of the LC. Structural characteristics of the LC have been widely explored in glaucoma management. However, information about which LC biomarkers could be useful for the diagnosis, and follow-up, of other diseases besides glaucoma is scarce. Hence, this literature review aims to summarize the role of the LC in nonophthalmic and ophthalmic diseases other than glaucoma. PubMed was used to perform a systematic review on the LC features that can be extracted from OCT images. All imaging features are presented and discussed in terms of their importance and applicability in clinical practice. A total of 56 studies were included in this review. Overall, LC depth (LCD) and thickness (LCT) have been the most studied features, appearing in 75% and 45% of the included studies, respectively. These biomarkers were followed by the prelaminar tissue thickness (21%), LC curvature index (5.4%), LC global shape index (3.6%), LC defects (3.6%), and LC strains/deformations (1.8%). Overall, the disease groups showed a thinner LC (smaller LCT) and a deeper ONH cup (larger LCD), with some exceptions. A large variability between approaches used to compute LC biomarkers has been observed, highlighting the importance of having automated and standardized methodologies in LC analysis. Moreover, further studies are needed to identify the pathologies where LC features have a diagnostic and/or prognostic value.
Language: English
Type (Professor's evaluation): Dissemination
No. of pages: 31
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

A Critical Analysis of the Available In Vitro and Ex Vivo Methods to Study Retinal Angiogenesis (2017)
Another Publication in an International Scientific Journal
Moleiro, AF; Conceicao, G; Leite-Moreira AF; Rocha-Sousa A
Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes (2017)
Article in International Scientific Journal
Pedrosa, AC; Sousa, T; Pinheiro Costa, J; Beato, J; Manuel Falcão; Falcão-Reis F; Ângela Carneiro
The Prevalence of Undiagnosed Age-Related Sight-Threatening Diseases in Self-Proclaimed Healthy Individuals (2020)
Article in International Scientific Journal
Lemmens, S; Barbosa Breda, JB; Van Keer, K; Jacobs, T; Van Landeghem, R; De Boever, P; Stalmans, I
Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results (2017)
Article in International Scientific Journal
Cardoso, PN; Pinheiro, AF; Meira, J; Pedrosa, AC; Manuel Falcão; Pinheiro Costa, J; Falcão-Reis F; Ângela Carneiro
Structural and Biomechanical Corneal Differences between Type 2 Diabetic and Nondiabetic Patients (2019)
Article in International Scientific Journal
Beato, JN; Esteves Leandro, J; Reis, D; Manuel Falcão; Rosas, V; Carneiro, Â; Falcão-Reis F; Huerva, V

See all (17)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-11 at 06:52:48 | Privacy Policy | Personal Data Protection Policy | Whistleblowing